Free Trial

NexgenRx Q1 2024 Earnings Report

C$0.27 -0.01 (-1.82%)
As of 02/14/2025

NexgenRx EPS Results

Actual EPS
C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NexgenRx Revenue Results

Actual Revenue
$4.29 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NexgenRx Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

NexgenRx Earnings Headlines

Your trading day could end at 11 AM
What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?
NexgenRX Inc.
Closing Bell: Nexgenrx Inc up on Monday (NXG)
See More NexgenRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NexgenRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexgenRx and other key companies, straight to your email.

About NexgenRx

NexgenRx (CVE:NXG) administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

View NexgenRx Profile

More Earnings Resources from MarketBeat